冠石科技再融资审核推进，光掩膜版项目进入试产阶段

Group 1: Capital Increase - The company received an inquiry letter from the Shanghai Stock Exchange regarding its application for a private placement of shares on January 16, 2026, and completed its response on February 12, 2026. The fundraising plan aims to raise no more than 700 million yuan, primarily for the photomask manufacturing project and to supplement working capital. The outcome and timing of this matter remain uncertain as it requires approval from the Shanghai Stock Exchange and registration consent from the China Securities Regulatory Commission [1] Group 2: Project Progress - The photomask project has accumulated an investment of 1.309 billion yuan, accounting for 67.79% of the total investment. Key developments include the arrival of production equipment for the 28nm production line in January 2026, with plans to initiate small-scale trial production in the second quarter of 2026, targeting mid-to-high-end products ranging from 180nm to 28nm. The project is currently in the customer sample verification stage, with 55nm and 40nm products still under validation, and large-scale sales have not yet formed. Technological breakthroughs and customer certification progress may have a long-term impact on the business transformation [2] Group 3: Financial Performance - The company has released a profit forecast, expecting a net loss attributable to shareholders of 56 million to 84 million yuan for the full year of 2025, primarily due to increased depreciation and amortization costs related to the photomask project. The formal annual report has not yet been disclosed, and attention should be paid to the release of audited financial data in the future. The performance may reflect short-term pressure on profitability due to new business investments [3] Group 4: Regulatory Oversight - The Shanghai Stock Exchange focused on the rationale for changing the use of previously raised funds (originally intended for functional structural components and other projects) to the photomask project in its inquiry letter. The company responded that the previous funds were fully utilized by December 31, 2025, and the current fundraising is clearly delineated from prior investments. The regulatory review outcome may involve corporate governance and the efficiency of fund utilization [4]